Kikuchi-Fujimoto Disease

Kikuchi-Fujimoto Disease
Carlos E. Bueso-Ramos, MD, PhD
Cervical lymph node involved by Kikuchi-Fujimoto disease. The paracortex shows a circumscribed, wedgeshaped area of necrosis that extends to the capsule.
MIP FDG-PET scan of Kikuchi-Fujimoto disease. This image reveals an area of FDG uptake in the right cervical region that was interpreted as suspicious for lymphoma image.
TERMINOLOGY
Abbreviations
  • Kikuchi-Fujimoto disease (KFD)
Synonyms
  • Necrotizing lymphadenitis without granulocytic infiltration
  • Histiocytic necrotizing lymphadenitis
  • Kikuchi-Fujimoto lymphadenopathy
Definitions
  • Self-limited, benign form of lymphadenopathy characterized by
    • Proliferation of histiocytes and plasmacytoid monocytes
    • Apoptosis with abundant karyorrhectic debris
    • Systemic symptoms and low-grade fever in subset of patients
ETIOLOGY/PATHOGENESIS
Unknown
  • Viral, infectious, or autoimmune cause has been suggested
  • Exuberant T-cell-mediated response to variety of stimuli in genetically susceptible people
  • Cytokine-mediated mechanisms
    • ↑ interleukin-6, interferon-α, FAS ligand
  • Viruses suggested to be involved in KFD include
    • Epstein-Barr virus (EBV) and human herpes virus 6 (HHV6)
    • Identified in small subset of cases; unlikely to be cause
CLINICAL ISSUES
Epidemiology
  • Age
    • Usually < 30 years (range: 2-75 years)
  • Gender
    • Women are affected more often
      • Female to male ratio is 4:1
  • Ethnicity
    • KFD has been described in a variety of ethnic backgrounds
      • Asian descent most common
Site
  • Lymphadenopathy
    • Cervical lymph nodes most often involved
Presentation
  • Fever typically lasts for 1 week
    • Can persist for up to 1 month
  • Upper respiratory symptoms
  • Most common initial manifestations are
    • Tender and painful lymphadenopathy
    • Lymphadenopathy with fever
  • Uncommon manifestations
    • Weight loss, night sweats, nausea, vomiting
    • Generalized lymphadenopathy
    • Joint pain
    • Extranodal involvement by KFD
    • Splenomegaly, hepatomegaly
Laboratory Tests
  • Rule out other causes of necrotizing lymphadenopathy
  • No specific tests are available for detecting KFD
  • Anemia
  • Elevated lactate dehydrogenase levels
  • Granulocytopenia and atypical lymphocytosis in peripheral blood (50%)
  • Elevated erythrocyte sedimentation rates
  • Polyclonal hypergammaglobulinemia
  • Negative serologic studies for
    • EBV, Cytomegalovirus, influenza, adenovirus
    • Toxoplasmosis, Mycoplasma, Q fever
  • Usually negative autoimmune laboratory studies
    • Antinuclear antibodies, rheumatoid factor, antidouble-strand DNA antibodies
    • Rare patients with KFD are subsequently diagnosed to have systemic lupus erythematosus
Natural History
  • Diagnosis is usually established by lymph node biopsy
    • Excisional biopsy is often required because KFD can be patchy
      • Assessment of lymph node architecture is very helpful in establishing diagnosis
  • Spontaneous resolution occurs, usually within 1-4 months
  • Small (˜ 3%) subset of patients develop relapse
Treatment
  • No specific therapy required
  • Anti-inflammatory agents
Prognosis
  • Excellent
IMAGE FINDINGS
CT Findings
  • Computed tomography (CT) is preferred modality
  • Cervical lymph nodes in KFD tend to be located in posterior triangle
  • Lymph nodes appear as clusters
    • < 4 cm in greatest dimension
    • Nonenhancing necrosis
  • Any lymph node group can be involved in KFD
MACROSCOPIC FEATURES
General Features
  • Size: 0.5-4.0 cm
MICROSCOPIC PATHOLOGY
Histologic Features
  • Lymph node
    • Architecture: Partial or extensive involvement
      • Often patchy in early stages
    • KFD begins in paracortex and near capsule
      • Degree of apoptosis/necrosis varies from one case to another
      • No granulocytes identified in necrotic areas
      • Plasma cells usually absent or rare
      • Process does not extend into perinodal tissues
      • Immunoblasts are numerous in viable paracortex contiguous with necrosis
      • No hematoxylin bodies identified
    • Sinuses are patent or compressed
      • Can be filled by histiocytes or monocytoid B cells
    • Hyperplastic lymphoid follicles in uninvolved areas
    • ± thrombosed blood vessels
    • 3 histologic subtypes of KFD have been described
      • Lymphohistiocytic/proliferative; thought to be early stage
      • Necrotic
      • Phagocytic/foamy cell; thought to be late stage
    • > 1 stage of KFD can be present within lymph node
    • Lymphohistiocytic/proliferative type
      • Proliferation of histiocytes (including C-shaped forms)
      • Increased plasmacytoid dendritic cells
      • Small lymphocytes and immunoblasts are present
      • Relatively little apoptosis or necrotic debris
    • Necrotic type
      • Abundant apoptosis within distinct foci of necrosis associated with eosinophilic debris
      • Histiocytes and plasmacytoid dendritic cells undergo apoptosis
      • Fibrin thrombi may be present in blood vessels
    • Phagocytic/foamy cell type
      • Numerous histiocytes containing phagocytosed debris (foamy cytoplasm)
      • Histiocytes often form rim surrounding necrotic areas
Cytologic Features
  • Diagnosis can be suggested in touch imprints of lymph node
    • Highlights cytologic characteristics of plasmacytoid dendritic cells (pDC)
    • Touch imprint often better than fine needle aspiration (FNA) smears
  • Frequency of CD123(+) pDC is high in KFD
    • Valuable indicator for diagnosis of KFD
    • Useful for distinguishing KFD from reactive lymphadenopathy and neoplasms
Skin
  • Most frequently located on face or upper body
  • KFD in skin can grossly present as
    • Erythematous papules
    • Indurated lesions or plaques
    • Ulcers
  • Histologic findings in skin include
    • Dermal lymphohistiocytic infiltrate; most common
    • Epidermal changes
      • Necrotic keratinocytes
      • Nonneutrophilic karyorrhectic debris
      • Basal vacuolar change
    • Edema of papillary dermis
ANCILLARY TESTS
Immunohistochemistry
  • Histiocytes are CD4(+), CD68(+), lysozyme(+), myeloperoxidase(+, dim)
  • Plasmacytoid dendritic cells are
    • CD68(+), CD123(+), CD303(+)
    • Myeloperoxidase(-), fascin(-)
  • T cells are predominantly CD8(+)
  • Immunoblasts are CD30(+) and of CD8(+) T-cell lineage
  • B cells are rare or absent in areas of necrosis
Flow Cytometry
  • Predominance of CD8(+) T cells without aberrancies
  • Rare polytypic B cells
  • Insufficient to establish diagnosis of KFD
    • Helpful to exclude non-Hodgkin lymphoma
Jul 8, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Kikuchi-Fujimoto Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access